Ignite Creation Date:
2024-05-05 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00262483
Status:
COMPLETED
Last Update Posted:
2007-12-21
First Post:
2005-12-02
Brief Title:
Phase 2 Study of VX-950 Pegasys and Copegus in Hepatitis C
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Organization Data
Organization:
Vertex Pharmaceuticals Incorporated
Class:
INDUSTRY
Study ID:
VX05-950-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vertex Pharmaceuticals Incorporated
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Robert Kauffman MD PhD
Old Organization:
Vertex Pharmaceuticals Incorporated